[go: up one dir, main page]

ES507595A0 - Un procedimiento para la produccion de un plasmido recombi- nante. - Google Patents

Un procedimiento para la produccion de un plasmido recombi- nante.

Info

Publication number
ES507595A0
ES507595A0 ES507595A ES507595A ES507595A0 ES 507595 A0 ES507595 A0 ES 507595A0 ES 507595 A ES507595 A ES 507595A ES 507595 A ES507595 A ES 507595A ES 507595 A0 ES507595 A0 ES 507595A0
Authority
ES
Spain
Prior art keywords
procedure
production
recombinant plasmid
plasmid
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES507595A
Other languages
English (en)
Other versions
ES8303529A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JURIDICAL FOUN JAPANESE FOUND
Original Assignee
JURIDICAL FOUN JAPANESE FOUND
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP13928979A external-priority patent/JPS5663996A/ja
Priority claimed from JP3393180A external-priority patent/JPS56131598A/ja
Application filed by JURIDICAL FOUN JAPANESE FOUND filed Critical JURIDICAL FOUN JAPANESE FOUND
Publication of ES507595A0 publication Critical patent/ES507595A0/es
Publication of ES8303529A1 publication Critical patent/ES8303529A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
ES507595A 1979-10-30 1981-11-30 Un procedimiento para la produccion de un plasmido recombi- nante. Expired ES8303529A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13928979A JPS5663996A (en) 1979-10-30 1979-10-30 Novel recombinant having gene complementary to human interferon messenger rna
JP3393180A JPS56131598A (en) 1980-03-19 1980-03-19 Novel recombinant plasmid having gene of human fibroblastic interferon messenger rna

Publications (2)

Publication Number Publication Date
ES507595A0 true ES507595A0 (es) 1983-02-01
ES8303529A1 ES8303529A1 (es) 1983-02-01

Family

ID=26372701

Family Applications (3)

Application Number Title Priority Date Filing Date
ES496426A Expired ES8203102A1 (es) 1979-10-30 1980-10-30 Un procedimiento para la preparacion de un adn que codifica un polipeptido con actividad de interferon.
ES507595A Expired ES8303529A1 (es) 1979-10-30 1981-11-30 Un procedimiento para la produccion de un plasmido recombi- nante.
ES507596A Expired ES8303530A1 (es) 1979-10-30 1981-11-30 Un procedimiento para la preparacion de un microorganismo que contiene un plasmido recombinante de un adn

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES496426A Expired ES8203102A1 (es) 1979-10-30 1980-10-30 Un procedimiento para la preparacion de un adn que codifica un polipeptido con actividad de interferon.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES507596A Expired ES8303530A1 (es) 1979-10-30 1981-11-30 Un procedimiento para la preparacion de un microorganismo que contiene un plasmido recombinante de un adn

Country Status (8)

Country Link
EP (1) EP0028033B1 (es)
AU (1) AU538665B2 (es)
CA (1) CA1341563C (es)
DE (1) DE3071435D1 (es)
DK (1) DK458480A (es)
ES (3) ES8203102A1 (es)
IL (1) IL61366A (es)
NO (1) NO158950C (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554513A (en) * 1979-11-21 1996-09-10 Yeda Research & Development Co. Ltd. Production of recombinant human interferon-beta2
US5510472A (en) * 1979-11-21 1996-04-23 Yeda Research And Development Co. Ltd. Production of recombinant human interferon-beta2
NO164037C (no) * 1980-01-08 1990-08-22 Biogen Inc Fremgangsmaate ved fremstilling av et polypeptid av interferon alfa (ifnalfa)-type.
US6835557B1 (en) 1980-01-08 2004-12-28 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human interferon-like polypeptides
DK33181A (da) * 1980-02-06 1981-08-07 Searle & Co Fremgangsmaade til fremstilling af et interferonlignende protein
DE3005843A1 (de) * 1980-02-16 1981-09-10 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
AU564690B2 (en) * 1980-04-03 1987-08-20 Biogen Idec Ma Inc. Process for producing human fibroblast interferon-like polypeptides using recombinant dna
IT1139487B (it) * 1980-09-25 1986-09-24 Genentech Inc Produzione microbica di interferone di fibroblasti umani
DE3280127D1 (de) * 1981-03-27 1990-04-12 Ici Plc Genetisch modifizierte mikroorganismen.
IL65475A0 (en) * 1981-04-17 1982-07-30 Meloy Lab Production of immune interferon and its mrna
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
US4450103A (en) * 1982-03-01 1984-05-22 Cetus Corporation Process for recovering human IFN-β from a transformed microorganism
US5827694A (en) * 1982-03-08 1998-10-27 Genentech, Inc. DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
DE3220116A1 (de) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
US4737462A (en) * 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4588585A (en) * 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
US5831023A (en) * 1982-11-01 1998-11-03 Genentech, Inc. Recombinant animal interferon polypeptides
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US4855238A (en) 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
US5425940A (en) * 1986-04-09 1995-06-20 Cetus Oncology Corporation Combination therapy using interleukin-2 and tumor necrosis factor
DE3751409T2 (de) 1986-04-15 1996-01-25 Ciba Geigy Ag Monoklonale Antikörper gegen Interferon-induziertes humanes Protein in gereignigter Form, und diese Antikörper enthaltende Testsätze.
US4961969A (en) * 1987-05-11 1990-10-09 Cetus Corporation Process for recovering microbially produced interferon-β
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
GB9506051D0 (en) 1995-03-24 1995-05-10 Univ Singapore Gene expression
ES2223017T5 (es) 1997-09-23 2010-10-15 Rentschler Biotechnologie Gmbh Formulaciones liquidas de un interferon beta.
WO2001077137A1 (en) 2000-04-12 2001-10-18 Human Genome Sciences, Inc. Albumin fusion proteins
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
EP2277889B1 (en) 2001-12-21 2014-07-09 Human Genome Sciences, Inc. Fusion proteins of albumin and interferon beta
EP1594530A4 (en) 2003-01-22 2006-10-11 Human Genome Sciences Inc HYBRID PROTEINS OF ALBUMIN
PL3321359T3 (pl) 2005-04-11 2021-06-28 Horizon Pharma Rheumatology Llc Wariantowe postacie oksydazy moczanowej i ich zastosowanie
EP2013225B1 (en) 2006-04-12 2014-12-17 Crealta Pharmaceuticals LLC Purification of proteins with cationic surfactant
WO2009045553A1 (en) 2007-10-05 2009-04-09 Barofold, Inc. High pressure treatment of aggregated interferons
PL398781A1 (pl) 2009-06-25 2012-11-19 Savient Pharmaceuticals, Inc. Sposoby i zestawy do prognozowania ryzyka wystapienia reakcji na wlew oraz zaniku odpowiedzi której posrednicza przeciwciala poprzez monitorowanie kwasu moczowego w surowicy podczas terapii z zastosowaniem pegylowanej urykazy
DE102009032179A1 (de) 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta
EP3538135A4 (en) 2016-11-11 2020-07-29 Horizon Pharma Rheumatology LLC POLYTHERAPIES OF PREDNISONE AND URICASE MOLECULES AND THEIR USES
US20200237881A1 (en) 2019-01-30 2020-07-30 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Also Published As

Publication number Publication date
DK458480A (da) 1981-05-01
IL61366A (en) 1983-11-30
DE3071435D1 (en) 1986-03-27
EP0028033B1 (en) 1986-02-19
ES496426A0 (es) 1982-02-16
CA1341563C (en) 2007-12-04
ES507596A0 (es) 1983-02-01
ES8303530A1 (es) 1983-02-01
EP0028033A2 (en) 1981-05-06
IL61366A0 (en) 1980-12-31
NO158950C (no) 1988-11-16
NO158950B (no) 1988-08-08
AU538665B2 (en) 1984-08-23
ES8303529A1 (es) 1983-02-01
EP0028033A3 (en) 1981-08-19
AU6376280A (en) 1981-05-07
ES8203102A1 (es) 1982-02-16
NO803230L (no) 1981-05-04

Similar Documents

Publication Publication Date Title
ES507595A0 (es) Un procedimiento para la produccion de un plasmido recombi- nante.
ES492053A0 (es) Un procedimiento para la produccion de un plasmido.
ES491534A0 (es) Un procedimiento para la preparacion de nuevos bis-esteres de metanodiol.
ES495134A0 (es) Un procedimiento para la preparacion de copoliesteres formadores de fibras.
ES497304A0 (es) Un procedimiento para la preparacion de nuevos derivados de diarilamino-fluorano.
ES487852A0 (es) Un procedimiento para la preparacion de interferon tipo ii.
ES490645A0 (es) Un procedimiento para la produccion de un derivado 4-amino- 3-carboxi o ciano-1,2-dihidro-2-oxo-1,8-naftiridina
ES494435A0 (es) Un procedimiento para la preparacion de nuevos antibioticos de milbecina.
ES487843A0 (es) Un procedimiento para la preparacion de derivados de imida- zol.
ES494131A0 (es) Un procedimiento para la preparacion de diariltiofenos.
ES491944A0 (es) Un procedimiento para la preparacion de tienamicinas.
ES488886A0 (es) Un procedimiento para la preparacion de derivados acidos penemcarboxilicos.
ES487833A0 (es) Procedimiento para la produccion de un preparado farmaceuti-co
ES495586A0 (es) Un procedimiento para la preparacion de derivados de oxazo- lidona- o tiazolidona.
ES495163A0 (es) Un procedimiento para la preparacion de derivados de carboestirilo.
ES491835A0 (es) Un procedimiento para la preparacion de mono-y-di-esteres desacarosa.
ES506994A0 (es) Un procedimiento para la produccion de un plasmido.
ES490722A0 (es) Un procedimiento para la preparacion de nuevos derivados de piridazina.
ES507997A0 (es) Un procedimiento para la preparacion de nuevos derivados de la quinoleina.
ES497525A0 (es) Un procedimiento para la produccion de derivados de halogeno-triacinilo.
ES489127A0 (es) Un procedimiento para la preparacion de nuevos 1, 2, 4-tria-zoles.
ES492443A0 (es) Un procedimiento para la produccion de cefamicina c.
ES495589A0 (es) Un procedimiento para la preparacion de derivados de imida- lol.
ES490277A0 (es) Un procedimiento para la preparacion de aminoeteres.
ES494130A0 (es) Un procedimiento para la preparacion de nuevos derivados de benzoxocina.